Market capitalization | €61.30b |
Enterprise Value | €69.33b |
P/E (TTM) P/E ratio | 23.34 |
EV/FCF (TTM) EV/FCF | 28.57 |
EV/Sales (TTM) EV/Sales | 3.32 |
P/S ratio (TTM) P/S ratio | 2.94 |
P/B ratio (TTM) P/B ratio | 2.15 |
Dividend yield | 1.56% |
Last dividend (FY23) | €2.20 |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
17 Analysts have issued a Merck forecast:
17 Analysts have issued a Merck forecast:
Jun '24 |
+/-
%
|
||
Revenue | 20,870 20,870 |
5%
5%
|
|
Gross Profit | 12,151 12,151 |
10%
10%
|
|
EBITDA | 6,211 6,211 |
13%
13%
|
EBIT (Operating Income) EBIT | 4,135 4,135 |
22%
22%
|
Net Profit | 2,625 2,625 |
15%
15%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Head office | Germany |
CEO | Belén López |
Employees | 62,908 |
Founded | 1995 |
Website | www.merckgroup.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.